Harnessing multi-omics to identify host-microbiome interactions driving HIV-associated chronic obstructive pulmonary disease in low and middle income countries
Overview
Organization: National Heart, Lung, and Blood Institute
Start Date: 09/2024
End Date: Ongoing
Primary Goal: Goal 4: Increase and sustain research to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD.
Secondary Goal(s):
Objective(s):
- Help expand, coordinate, and optimize COPD research efforts
Collaboration: Duke University
Activity Type: Research
Activity Description
Chronic obstructive pulmonary disease (COPD) is the third most common cause of death worldwide and people with HIV are at increased risk of developing COPD. I am a pulmonologist with expertise in global health research and microbiome science and here I propose a project to use multi-omics data to better understand how lung function loss and COPD develop in people with HIV in low- and middle-income countries, where over 80% of COPD deaths occur. This information will help us determine who is at highest risk for COPD and identify new therapeutic targets for COPD in people with HIV.Audience
General Audience: Researchers
Focused Audience: n/a
Program Reach: National
Type of Area: N/A
Setting: Workplace
Cost and Funding Sources
It was funded through the National Heart, Lung, and Blood Institute and funds to be allotted to grantees.Impact Analysis
Results of their programs are in progress.Advice or Lessons Learned
In process.Contact Information
National Heart, Lung, and Blood Institute
Program Analyst
Bethesda
Maryland